Sheaff Brock Investment Advisors, LLC Eli Lilly & CO Transaction History

Sheaff Brock Investment Advisors, LLC

$1.13 Billion
Q3 2024

A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 32,010 shares of LLY stock, worth $23.3 Million. This represents 2.51% of its overall portfolio holdings.

Number of Shares

32,010

Previous 34,457 7.1%

Holding current value

$23.3 Million

Previous $31.2 Million 9.1%

% of portfolio

2.51%

Previous 2.91%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $1.89 Million - $2.35 Million	-2,447 Reduced 7.1%	32,010 $28.4 Million
Q2 2024 Jul 30, 2024	SELL	$724.87 - $909.04 $1.54 Million - $1.93 Million	-2,128 Reduced 5.82%	34,457 $31.2 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $96,528 - $129,141	163 Added 0.45%	36,585 $28.5 Million
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $295,156 - $347,951	-562 Reduced 1.52%	36,422 $21.2 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $2.16 Million - $2.98 Million	-4,977 Reduced 11.86%	36,984 $19.9 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $744,971 - $996,113	-2,124 Reduced 4.82%	41,961 $19.7 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $103,439 - $121,485	333 Added 0.76%	44,085 $15.1 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $572,037 - $666,537	-1,779 Reduced 3.91%	43,752 $16 Million
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $1.1 Million - $1.26 Million	-3,721 Reduced 7.56%	45,531 $14.7 Million
Q2 2022 Aug 02, 2022	SELL	$278.73 - $327.27 $862,111 - $1.01 Million	-3,093 Reduced 5.91%	49,252 $16 Million
Q1 2022 May 06, 2022	BUY	$234.69 - $291.66 $134,007 - $166,537	571 Added 1.1%	52,345 $15 Million
Q4 2021 Feb 03, 2022	BUY	$224.85 - $279.04 $362,458 - $449,812	1,612 Added 3.21%	51,774 $14.3 Million
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $1.03 Million - $1.27 Million	-4,665 Reduced 8.51%	50,162 $11.6 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $213,590 - $276,277	1,183 Added 2.21%	54,827 $12.6 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $91,033 - $117,846	554 Added 1.04%	53,644 $10 Million
Q4 2020 Feb 01, 2021	SELL	$130.46 - $172.63 $16,307 - $21,578	-125 Reduced 0.23%	53,090 $8.96 Million
Q3 2020 Oct 30, 2020	BUY	$146.22 - $169.13 $4.13 Million - $4.78 Million	28,248 Added 113.14%	53,215 $7.88 Million
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $70,665 - $85,045	-518 Reduced 2.03%	24,967 $4.1 Million
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $148,217 - $183,450	-1,245 Reduced 4.66%	25,485 $3.54 Million
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $143,700 - $177,985	1,344 Added 5.29%	26,730 $3.51 Million
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $134,875 - $146,710	-1,263 Reduced 4.74%	25,386 $2.84 Million
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $262,239 - $306,100	-2,367 Reduced 8.16%	26,649 $2.95 Million
Q1 2019 Apr 29, 2019	BUY	$111.31 - $131.02 $57,102 - $67,213	513 Added 1.8%	29,016 $3.77 Million
Q4 2018 Jan 28, 2019	BUY	$105.9 - $118.64 $260,937 - $292,328	2,464 Added 9.46%	28,503 $3.3 Million
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $1.25 Million - $1.56 Million	-14,518 Reduced 35.8%	26,039 $2.79 Million
Q2 2018 Jul 31, 2018	SELL	$75.7 - $86.88 $71,460 - $82,014	-944 Reduced 2.27%	40,557 $3.46 Million
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $690,078 - $814,592	9,299 Added 28.88%	41,501 $3.21 Million
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $186,413 - $199,949	-2,275 Reduced 6.6%	32,202 $2.72 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $117,685 - $130,619	1,527 Added 4.63%	34,477 $2.95 Million
Q2 2017 Aug 09, 2017	BUY	N/A	32,950	32,950 $2.71 Million

Others Institutions Holding LLY

# of Institutions

4,002

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $691B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.

Account

Sheaff Brock Investment Advisors, LLC Eli Lilly & CO Transaction History